TRISTAN HATTON: Open Payments
NPI 1750044376 · WASHINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 7 payments from 5 companies in 2025. Trend: 2023 $446 · 2024 $166 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 1 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Alkermes, Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: NUPLAZID, AUSTEDO XR, REXULTI, ARISTADA, COBENFY.
Industry payments across IN — which companies pay providers there.
